What problem does it solve? Biomedical research requires querying many separate databases (PubMed, ChEMBL, ClinicalTrials.gov, OpenTargets, OpenFDA, OMIM) with different APIs and ID formats, making drug repurposing and target discovery workflows slow and fragmented. ## Core Features & Use Cases - Unified MCP Endpoint: Access 14+ biomedical databases through one JSON-RPC endpoint with copy-paste curl commands and no setup required. - Complete Database Guides: Detailed references for PubMed, ClinicalTrials.gov, ChEMBL, OpenTargets, OpenFDA, OMIM, plus Reactome, UniProt, KEGG, GWAS, and ID-mapping services. - End-to-End Workflows: An 8-step drug repurposing pipeline covering target identification, drug screening, trial search, literature review, and safety assessment. - Use Case: Find repurposing candidates for myasthenia gravis by pulling disease targets from OpenTargets, matching drugs in ChEMBL, checking recruiting trials, and reviewing FDA adverse events. ## Quick Start Ask the agent to find approved and investigational drugs for myasthenia gravis using the ChEMBL indication search via the unified MCP endpoint.